Cytisine Pharmacokinetics and Dose Response (C-DRAKS 3 and C-DRAKS 4)
Clinical trial NCT02585024 · TERMINATED
Trial details
- NCT number
- NCT02585024
- Sponsor
- University of Auckland, New Zealand
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2019-03-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.